Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Elena Caldero-EscuderoDepartment de Biochemistry, Molecular Biology and Physiology, Faculty of Medicine, University of Valladolid (UVA), Ramón y Cajal, 7, E-47005 Valladolid, Spain.ORCID 0009-0000-0694-3243
Silvia Romero-SanzDepartment de Biochemistry, Molecular Biology and Physiology, Faculty of Medicine, University of Valladolid (UVA), Ramón y Cajal, 7, E-47005 Valladolid, Spain.ORCID 0000-0003-4671-7376
Pilar Álvarez-IlleraDepartment de Biochemistry, Molecular Biology and Physiology, Faculty of Medicine, University of Valladolid (UVA), Ramón y Cajal, 7, E-47005 Valladolid, Spain.
Silvia Fernandez-MartinezInstitute of Biomedicine and Molecular Genetics (IBGM), Higher Council for Scientific Research (CSIC)-University of Valladolid (UVA), Sanz y Fores, 3, E-47003 Valladolid, Spain.
Sergio De la FuenteDepartment de Biochemistry, Molecular Biology and Physiology, Faculty of Medicine, University of Valladolid (UVA), Ramón y Cajal, 7, E-47005 Valladolid, Spain.
Paloma García-CasasDepartment de Biochemistry, Molecular Biology and Physiology, Faculty of Medicine, University of Valladolid (UVA), Ramón y Cajal, 7, E-47005 Valladolid, Spain.
Rosalba I FonterizDepartment de Biochemistry, Molecular Biology and Physiology, Faculty of Medicine, University of Valladolid (UVA), Ramón y Cajal, 7, E-47005 Valladolid, Spain.ORCID 0000-0001-8349-6264
Mayte MonteroDepartment de Biochemistry, Molecular Biology and Physiology, Faculty of Medicine, University of Valladolid (UVA), Ramón y Cajal, 7, E-47005 Valladolid, Spain.
Javier AlvarezDepartment de Biochemistry, Molecular Biology and Physiology, Faculty of Medicine, University of Valladolid (UVA), Ramón y Cajal, 7, E-47005 Valladolid, Spain.ORCID 0000-0003-0636-5521
Jaime Santo-DomingoDepartment de Biochemistry, Molecular Biology and Physiology, Faculty of Medicine, University of Valladolid (UVA), Ramón y Cajal, 7, E-47005 Valladolid, Spain.ORCID 0000-0001-5501-0482
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
SERCA Silencing Alleviates Aß · full record | Socratic